Inoz\u012bts ir balts, \u016bden\u012b \u0161\u0137\u012bsto\u0161s cukura alkohols, kas ir uz pusi sald\u0101ks nek\u0101 galda cukurs. Var\u0113tu dom\u0101t, ka inozitola pulveris tiek ra\u017eots laboratorij\u0101, bet paties\u012bb\u0101 tas ir \u013coti bag\u0101t\u012bgi pieejams dab\u0101! L\u016bk, k\u0101p\u0113c:<\/p>\n\n\n\n
- \n
- Tas dabiski atrodas cilv\u0113ka \u0137ermen\u012b, \u012bpa\u0161i m\u016bsu smadzen\u0113s, audos un \u0161\u016bnu membr\u0101n\u0101s.<\/li>\n\n\n\n
- M\u016bsu nieres veido apm\u0113ram 2 gramus inozitola no glikozes (kas tiek p\u0101rveidots no og\u013chidr\u0101tiem, ko m\u0113s \u0113dam).<\/li>\n\n\n\n
- Lielos daudzumos tas ir atrodams ga\u013c\u0101, aug\u013cos (\u012bpa\u0161i citrusaug\u013cos), d\u0101rze\u0146os, graudos, riekstos un s\u0113kl\u0101s. T\u0101p\u0113c ir svar\u012bgi \u0113st vesel\u012bgu uzturu un nep\u0101rpild\u012bt sevi ar nev\u0113lamu p\u0101rtiku!<\/li>\n<\/ul>\n\n\n\n
Inoz\u012btu agr\u0101k sauca par B8 vitam\u012bnu, ta\u010du kop\u0161 t\u0101 laika tas ir p\u0101rklasific\u0113ts, jo tas \u012bsti nav vitam\u012bns. To ar\u012b neuzskata par b\u016btisku uzturvielu, jo organisms to ra\u017eo no glikozes sint\u0113zes. P\u0113c defin\u012bcijas b\u016btisk\u0101s uzturvielas ir t\u0101s, kas organismam ir vajadz\u012bgas, bet m\u0113s vai nu nevaram t\u0101s ra\u017eot, vai ar\u012b nesp\u0113jam ieg\u016bt pietiekami daudz. T\u0101tad, tas ir j\u0101ieg\u016bst ar di\u0113tu (vai uztura bag\u0101tin\u0101t\u0101jiem), lai apmierin\u0101tu \u0137erme\u0146a vajadz\u012bbas.<\/p>\n\n\n\n
![\"Mioinozitols](\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/07\/benefici-utilizzi-e-dosaggio-dell-inositolo-in-polvere-01-1024x608.jpg\")
<\/figure>\n\n\n\nKas ir Mio-inoz\u012bts?<\/strong><\/h2>\n\n\n\n
Inoz\u012btam ir 9 formas vai izom\u0113ri. Visizplat\u012bt\u0101k\u0101 un izplat\u012bt\u0101k\u0101 forma ir mioinoz\u012bts (vai mioinozitols). Mioinozitols ir tik bag\u0101t\u012bgs, ka ikreiz, kad j\u016bs las\u0101t vai dzirdat v\u0101rdu inoz\u012bts, tas paties\u012bb\u0101 ir mioinozitols, par ko tiek run\u0101ts. Ja nepiecie\u0161ams, cilv\u0113ka \u0137ermenis var p\u0101rv\u0113rst mioinoz\u012btu par citiem t\u0101 izom\u0113riem.<\/p>\n\n\n\n
L\u016bk ir citi inozitola izom\u0113ri:<\/p>\n\n\n\n
- \n
- D-hiroinozitols (otr\u0101 izplat\u012bt\u0101k\u0101 forma)<\/li>\n\n\n\n
- L-hiroinozitols<\/li>\n\n\n\n
- Sciloinozitols<\/li>\n\n\n\n
- Mukoinozitols<\/li>\n\n\n\n
- Neoinozitols<\/li>\n\n\n\n
- Alloinozitols<\/li>\n\n\n\n
- Epi-inozitols<\/li>\n\n\n\n
- Cis-inoz\u012bts<\/li>\n<\/ol>\n\n\n\n
Ja vien nav nor\u0101d\u012bts cit\u0101di, katru reizi, kad \u0161aj\u0101 zi\u0146\u0101 las\u0101t v\u0101rdu inoz\u012bts (vai \u0161aj\u0101 zi\u0146\u0101 m\u016bsu emu\u0101r\u0101), \u0146emiet v\u0113r\u0101, ka m\u0113s run\u0101jam par mioinozitolu<\/a>.<\/p>\n\n\n\n
Kas ir D-hiroinozitols?<\/strong><\/h2>\n\n\n\n
D-hiroinozitols ir v\u0113l viens inozitola izom\u0113rs. Lai gan dab\u0101 tas nav sastopams lielos daudzumos, tas ir otrs visizplat\u012bt\u0101kais inozitola veids blakus mioinozitolam. K\u0101 min\u0113ts iepriek\u0161, m\u016bsu \u0137ermenis vajadz\u012bbas gad\u012bjum\u0101 var p\u0101rv\u0113rst mioinozitolu par d-hiroinozitolu.<\/p>\n\n\n\n
Norm\u0101l\u0101 mioinoz\u012bta un d-hiroinoz\u012bta attiec\u012bba organism\u0101 ir 40:1. Liel\u0101k\u0101 da\u013ca inozitola mais\u012bjumu (piedevu) pied\u0101v\u0101 mioinoz\u012bta un d-hiroinoz\u012bta kombin\u0101ciju \u0161aj\u0101 proporcij\u0101.<\/p>\n\n\n\n
![\"K\u0101p\u0113c](\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/07\/benefici-utilizzi-e-dosaggio-dell-inositolo-in-polvere-02-1024x538.jpg\")
<\/figure>\n\n\n\nK\u0101d\u0113\u013c inoz\u012bta pulveris?<\/strong><\/h2>\n\n\n\n
Inoz\u012btu var ieg\u0101d\u0101ties pulvera, table\u0161u vai kapsulu veid\u0101. Lai gan da\u017ei z\u012bmoli pied\u0101v\u0101 abus veidus, m\u0113s uzskat\u0101m, ka inozitola pulveris ir daudz lab\u0101ks risin\u0101jums. Bet nedom\u0101jiet par m\u016bsu v\u0101rdiem, p\u0101rbaudiet katra form\u0101ta plusus un m\u012bnusus, lai j\u016bs var\u0113tu izlemt pats!<\/p>\n\n\n\n
Inoz\u012bta pulveris<\/strong><\/h3>\n\n\n\n
Ikdienas inozitola devas uz\u0146em\u0161ana var \u0161\u0137ist apgr\u016btino\u0161a, ta\u010du paties\u012bb\u0101 t\u0101 ir praktisk\u0101ka iesp\u0113ja. K\u0101 j\u016bs uzzin\u0101sit v\u0113l\u0101k \u0161aj\u0101 rakst\u0101, inozitola devas at\u0161\u0137iras atkar\u012bb\u0101 no slim\u012bbas. Pulvera forma \u013cauj viegli piel\u0101got devu.<\/p>\n\n\n\n
Piem\u0113ram, ja ra\u017eot\u0101js saka, ka 1 m\u0113rkarote ir 1 porcija, ir viegli noteikt, cik kausi\u0146u(-s) ir jums nepiecie\u0161ami. Lai sa\u0146emtu pusi porcijas, pa\u0146emiet tikai pusi karotes. Lai dubultotu vai tr\u012bsk\u0101r\u0161otu savu porciju, jums vajadz\u0113s divus vai tr\u012bs kausi\u0146us! Viegli!<\/p>\n\n\n\n
Ar\u012b inozitola pulveris ir \u013coti viegli uz\u0146emt. Jums tas vienk\u0101r\u0161i j\u0101sajauc ar \u016bdeni vai k\u0101du citu \u0161\u0137idru dz\u0113rienu un p\u0113c tam j\u0101izdzer. Da\u017ei z\u012bmoli apgalvo, ka tiem ir neitr\u0101las gar\u0161as inozitola pulveris, ta\u010du paties\u012bb\u0101 inozitola gar\u0161a ir nedaudz salda. T\u0101tad tas ir lieliski piem\u0113rots r\u012bta kafijas vai t\u0113jas saldin\u0101\u0161anai.<\/p>\n\n\n\n
Inoz\u012bta tablete vai kapsula<\/strong><\/h3>\n\n\n\n
Inoz\u012btu p\u0101rdod ar\u012b table\u0161u vai kapsulu form\u0101t\u0101. Tas patie\u0161\u0101m ir \u0113rt\u0101ks risin\u0101jums, jo j\u016bs varat vienk\u0101r\u0161i ieb\u0101zt mut\u0113 vienu vai divas tabletes un noskalot ar \u016bdeni. Tom\u0113r devas piel\u0101go\u0161ana nav tik vienk\u0101r\u0161a.<\/p>\n\n\n\n
Piem\u0113ram, da\u017ei z\u012bmoli pras\u012bs jums katru dienu lietot 4 tabletes, lai sasniegtu nepiecie\u0161amo porcijas lielumu. Tas noz\u012bm\u0113, ka, ja v\u0113laties dubultot vai pat tr\u012bsk\u0101r\u0161ot porcijas lielumu (j\u0101, inoz\u012bts ir dro\u0161s pat liel\u0101s dev\u0101s \u2014 vair\u0101k par to t\u0101l\u0101k), j\u016bs vien\u0101 dien\u0101 izdzersiet 8 vai pat 12 tabletes! Es nezinu k\u0101 jums, bet priek\u0161 manis tas ir p\u0101r\u0101k daudz!<\/p>\n\n\n\n
Kapsulas ir pietiekami viegli iedzert, lai sa\u0146emtu iek\u0161\u0101 eso\u0161o pulveri. Bet k\u0101p\u0113c iet cauri vis\u0101m gr\u016bt\u012bb\u0101m? Vispirms ieg\u016bstiet inoz\u012bta pulveri!<\/p>\n\n\n\n
![\"Inoz\u012bta](\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/07\/3-28-1024x530.jpg\")
<\/figure>\n\n\n\nK\u0101di ir inoz\u012bta ieguvumi vesel\u012bbai?<\/strong><\/h2>\n\n\n\n
T\u0101d\u0113\u013c inoz\u012btam ir tik daudz vesel\u012bbas ieguvumu, m\u0113s sadal\u012bsim \u0161o sada\u013cu 3 da\u013c\u0101s \u2013 ieguvumi vesel\u012bbai ikvienam, ieguvumi vesel\u012bbai sieviet\u0113m un vesel\u012bbas ieguvumi v\u012brie\u0161iem.<\/p>\n\n\n\n
8 ieguvumi vesel\u012bbai gan v\u012brie\u0161iem, gan sieviet\u0113m<\/strong><\/h3>\n\n\n\n
1. Inoz\u012bts veicina jut\u012bbu pret insul\u012bnu<\/strong><\/h4>\n\n\n\n
Insul\u012bns ir svar\u012bgs hormons, kas tiek ra\u017eots aizku\u0146\u0123a dziedzer\u012b. Tas regul\u0113 cukura l\u012bmeni asin\u012bs organism\u0101, un tam ir ar\u012b noz\u012bme tauku un olbaltumvielu metabolism\u0101. Slikta jut\u012bba pret insul\u012bnu, jeb insul\u012bna rezistence, palielina 2. tipa diab\u0113ta, metabolisk\u0101 sindroma, PCOS, sirds slim\u012bbu un citu risku.<\/p>\n\n\n\n
T\u0101tad, k\u0101 tie\u0161i inoz\u012bts uzlabo jut\u012bbu pret insul\u012bnu? Lai atbild\u0113tu uz \u0161o jaut\u0101jumu, apskat\u012bsim attiec\u012bbas starp og\u013chidr\u0101tiem un insul\u012bnu:<\/p>\n\n\n\n
Papildus vitam\u012bniem un miner\u0101lviel\u0101m, m\u0113s no p\u0101rtikas uz\u0146emam ar\u012b taukus, olbaltumvielas un og\u013chidr\u0101tus. Og\u013chidr\u0101ti ir m\u016bsu \u0137erme\u0146a galvenais ener\u0123ijas avots. Kad og\u013chidr\u0101ti non\u0101k zarn\u0101s, tie tiek sadal\u012bti glikoz\u0113 vai asins cukur\u0101. Kad cukurs non\u0101ks asinsrit\u0113, cukura l\u012bmenis asin\u012bs dabiski palielin\u0101sies. Tas ir sign\u0101ls aizku\u0146\u0123a dziedzerim, lai atbr\u012bvotu insul\u012bnu asinsrit\u0113. Insul\u012bna uzdevums ir p\u0101rvietot glikozi \u0161\u016bn\u0101s, kur to izmanto k\u0101 ener\u0123iju vai uzglab\u0101 k\u0101 taukus. \u0160is process \u013cauj normaliz\u0113t cukura l\u012bmeni asin\u012bs.<\/p>\n\n\n\n
Probl\u0113mas sakne ir \u0161\u0101da:<\/p>\n\n\n\n
Ilgsto\u0161i \u0113dot p\u0101r\u0101k daudz og\u013chidr\u0101tu saturo\u0161u p\u0101rtikas produktu, var rasties insul\u012bna rezistence. Atcerieties, ka vair\u0101k og\u013chidr\u0101tu = augst\u0101ks cukura l\u012bmenis asin\u012bs. \u0160is og\u013chidr\u0101tu p\u0101rpalikums galu gal\u0101 noved\u012bs pie t\u0101, ka aizku\u0146\u0123a dziedzeris p\u0101ries hiperre\u017e\u012bm\u0101, lai ra\u017eotu v\u0113l vair\u0101k insul\u012bna. Agr\u0101k vai v\u0113l\u0101k \u0161\u016bnas p\u0101rst\u0101j rea\u0123\u0113t uz insul\u012bnu. Kad tas notiks, jums b\u016bs gan augsts cukura l\u012bmenis asin\u012bs, gan augsts insul\u012bna l\u012bmenis. Ja to ne\u0101rst\u0113, tas var izrais\u012bt insul\u012bna pretest\u012bbu.<\/p>\n\n\n\n
Par laimi, inoz\u012bts var pal\u012bdz\u0113t uzlabot insul\u012bna j\u016bt\u012bbu. Vair\u0101ki kl\u012bniskie p\u0113t\u012bjumi apstiprina faktu, ka inoz\u012bts var samazin\u0101t cukura l\u012bmeni asin\u012bs, k\u0101 ar\u012b insul\u012bna l\u012bmeni, t\u0101d\u0113j\u0101di uzlabojot jut\u012bbu pret insul\u012bnu gan PCOS pacientiem, gan pacientiem, kuriem nav PCOS. (1, 2).<\/p>\n\n\n\n
![\"Inoz\u012bts](\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/07\/4-10-1024x516.jpg\")
<\/figure>\n\n\n\n2. Tas samazina ZBL holester\u012bna un kop\u0113j\u0101 holester\u012bna l\u012bmeni<\/strong><\/h4>\n\n\n\n
Iesp\u0113jams, ka holester\u012bns p\u0113d\u0113jo desmitga\u017eu laik\u0101 ir sa\u0146\u0113mis sliktu revol\u016bciju, ta\u010du paties\u012bb\u0101 tas ir diezgan svar\u012bga uzturviela, kas atrodama vis\u0101s m\u016bsu \u0161\u016bn\u0101s. Tas noz\u012bm\u0113, ka ir divu veidu holester\u012bns:<\/p>\n\n\n\n
- \n
- Zema bl\u012bvuma lipoprote\u012bns (ZBL) – tas ir “slikts” holester\u012bns. Augsts ZBL l\u012bmenis palielina insulta un sirds slim\u012bbu risku.<\/li>\n\n\n\n
- Augsta bl\u012bvuma lipoprote\u012bns (ABL) \u2013 tas ir \u201clabais\u201d holester\u012bns. Augsts ABL l\u012bmenis samazina insulta un sirds slim\u012bbu risku.<\/li>\n<\/ul>\n\n\n\n
\u0160ie divi kop\u0101 veido j\u016bsu kop\u0113jo holester\u012bna l\u012bmeni. <\/p>\n\n\n\n
Saska\u0146\u0101 ar p\u0101rskatu par 14 randomiz\u0113tiem kontrol\u0113tiem p\u0113t\u012bjumiem, kas public\u0113ti 2018. gad\u0101, inozitola papildin\u0101\u0161ana iev\u0113rojami samazin\u0101ja ZBL un kop\u0113jo holester\u012bna l\u012bmeni. Inoz\u012bts neietekm\u0113ja ABL l\u012bmeni, ta\u010du tas nemazina faktu, ka inoz\u012bts var pal\u012bdz\u0113t samazin\u0101t insulta un sirds slim\u012bbu risku (3)!<\/p>\n\n\n\n
3. Inoz\u012bts pal\u012bdz samazin\u0101t triglicer\u012bdu l\u012bmeni organism\u0101<\/strong><\/h4>\n\n\n\n
T\u0101pat k\u0101 sliktais holester\u012bns, ir svar\u012bgi ar\u012b p\u0101rvald\u012bt triglicer\u012bdu l\u012bmeni, jo augsts l\u012bmenis palielina insulta, sirds slim\u012bbu un sirdsl\u0113kmes risku. Diem\u017e\u0113l tiem, kuriem ir v\u0101ja jut\u012bba pret insul\u012bnu, ir ar\u012b augsts triglicer\u012bdu l\u012bmenis. Labi ir tas, ka vair\u0101ki p\u0113t\u012bjumi nor\u0101da uz faktu, ka inozitols pozit\u012bvi ietekm\u0113 plazmas triglicer\u012bdu l\u012bmeni (2, 3).<\/p>\n\n\n\n
Ir zin\u0101ms, ka ar\u012b omega 3 tauksk\u0101bes pal\u012bdz samazin\u0101t triglicer\u012bdu l\u012bmeni. Apskatiet \u0161o rakstu par 24 veidiem, k\u0101 omega 3 var pal\u012bdz\u0113t uzlabot j\u016bsu dz\u012bvi<\/a>!<\/p>\n\n\n\n
![\"Inoz\u012bts](\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/07\/5-6-1024x618.jpg\")
<\/figure>\n\n\n\n4. Atvieglo trauksmi, depresiju un panikas trauc\u0113jumus<\/strong><\/h4>\n\n\n\n
Saska\u0146\u0101 ar J. Levine, inozitolam ir terapeitiska iedarb\u012bba uz trauc\u0113jumiem, kas rea\u0123\u0113 uz SSAI<\/a> vai selekt\u012bviem seroton\u012bna atpaka\u013csaistes inhibitoriem. Tie ir antidepresanti, ko lieto, lai \u0101rst\u0113tu depresiju, obses\u012bvi kompuls\u012bvus sindromu (OKS), panikas sindromu un fobijas, piem\u0113ram, agorafobiju un soci\u0101lo fobiju (5).<\/p>\n\n\n\n
\u0160eit ir Levina atkl\u0101jumu kopsavilkums: <\/p>\n\n\n\n
Depresija<\/em><\/p>\n\n\n\n
28 pacientiem katru dienu tika ievad\u012bti 12 g inozitola. P\u0113c 4 ned\u0113\u013c\u0101m vi\u0146u gar\u012bgie apst\u0101k\u013ci uzr\u0101d\u012bja iev\u0113rojamu uzlabojumu saska\u0146\u0101 ar Hamiltona depresijas skalu.<\/p>\n\n\n\n
Panikas sindroms<\/em><\/p>\n\n\n\n
21 pacientam ar panikas sindromu (ar agorafobiju vai bez t\u0101s) 4 ned\u0113\u013cas sa\u0146\u0113ma 12 g inozitola dien\u0101. Rezult\u0101ti nebija vienk\u0101r\u0161i p\u0101rsteidzo\u0161i! Visi pacienti piedz\u012bvoja iev\u0113rojami maz\u0101k panikas l\u0113kmju epizo\u017eu, un, kad vi\u0146iem t\u0101s bija, t\u0101s nebija tik smagas k\u0101 iepriek\u0161.<\/p>\n\n\n\n
Obses\u012bvi kompuls\u012bvais sindroms<\/em><\/p>\n\n\n\n
P\u0113c 6 ned\u0113\u013cu ilgas 18 g inoz\u012bta lieto\u0161anas katru dienu 13 pacientiem ar OKT nov\u0113roja iev\u0113rojamu simptomu uzlabo\u0161anos.<\/p>\n\n\n\n
Saska\u0146\u0101 ar to pa\u0161u p\u0113t\u012bjumu inoz\u012bts nepal\u012bdz\u0113ja uzlabot apst\u0101k\u013cus, kas nerea\u0123\u0113 uz SSAI. Tie ietver t\u0101dus apst\u0101k\u013cus k\u0101 Alcheimera slim\u012bba, \u0161izofr\u0113nija un autisms.<\/p>\n\n\n\n
5. Inoz\u012bta pulveris liecina par bipol\u0101riem trauc\u0113jumiem <\/strong><\/h4>\n\n\n\n
M\u0113s visi ejam cauri emociju kalni\u0146iem, bet bipol\u0101ri cilv\u0113ki to pace\u013c l\u012bdz gal\u0113jam l\u012bmenim. Garast\u0101vok\u013ca sv\u0101rst\u012bbas ir \u013coti da\u017e\u0101das, s\u0101kot no ekstrem\u0101liem maksimumiem (m\u0101nijas) l\u012bdz gal\u0113jiem kritumiem (depresijai), starp kuriem ir da\u017ei stabili periodi.<\/p>\n\n\n\n
P\u0113t\u012bjums ar 24 bipol\u0101riem b\u0113rniem (vecum\u0101 no 5 l\u012bdz 12 gadiem) ar viegliem vai vid\u0113ji smagiem simptomiem atkl\u0101ja interesantu izn\u0101kumu. B\u0113rni tika sadal\u012bti 3 grup\u0101s. Vienai grupai tika dots inoz\u012bts, otrai grupai tika dota omega-3, bet p\u0113d\u0113jai grupai tika dots inoz\u012bts + omega-3 (6).<\/p>\n\n\n\n
P\u0113c 12 ned\u0113\u013c\u0101m grupa, kas lietoja inozitolu + omega-3, uzr\u0101d\u012bja visnoz\u012bm\u012bg\u0101ko bipol\u0101ro simptomu uzlabo\u0161anos. Tas ir saska\u0146\u0101 ar Young Mania Rating Scale un Children’s Depression Rating Scale (6).<\/p>\n\n\n\n
![\"Litija](\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/07\/benefici-utilizzi-e-dosaggio-dell-inositolo-in-polvere-06-1024x569.jpg\")
<\/figure>\n\n\n\n6. Pal\u012bdziet \u0101rst\u0113t litija izrais\u012btu psori\u0101zi<\/strong><\/h4>\n\n\n\n
Litijs ir garast\u0101vok\u013ca stabilizators, ko bie\u017ei izraksta bipol\u0101riem pacientiem. Tas darbojas, k\u0101 paredz\u0113ts, ta\u010du tam ir vair\u0101kas nev\u0113lamas blakuspar\u0101d\u012bbas, no kur\u0101m viena ir psori\u0101ze. Psori\u0101ze ir \u0101rk\u0101rt\u012bgi niezo\u0161a \u0101das slim\u012bba, kas izpau\u017eas k\u0101 pacelti, zv\u012b\u0146aini plankumi jebkur\u0101 \u0137erme\u0146a viet\u0101.<\/p>\n\n\n\n
Par laimi, p\u0101reja no litija uz inozitolu ir uzr\u0101d\u012bjusi neticamus rezult\u0101tus, par ko liecina gad\u012bjuma p\u0113t\u012bjums, kas veikts ar bipol\u0101ru pacientu. Litija viet\u0101 pacientam katru dienu izrakst\u012bja 3 g inozitola. P\u0113c 4 gadus ilgas regul\u0101ras nov\u0113ro\u0161anas p\u0113t\u012bjuma nosl\u0113gum\u0101 teikts, ka inoz\u012bts ir \u013coti efekt\u012bvs pacienta bipol\u0101ru simptomu un psori\u0101zes gad\u012bjum\u0101. (14).<\/p>\n\n\n\n
7. Var pal\u012bdz\u0113t zaud\u0113t svaru<\/strong><\/h4>\n\n\n\n
![\"Inoz\u012bta](\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/07\/7-2-1024x515.jpg\")
<\/figure>\n\n\n\n![\"Inoz\u012bts](\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/07\/8-3-1024x513.jpg\")
<\/figure>\n\n\n\n![\"Inoz\u012bta](\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/07\/9-4-1024x522.jpg\")
<\/figure>\n\n\n\n![\"Mioinozitols](\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/07\/10-1-1024x521.jpg\")
<\/figure>\n\n\n\n![\"Inoz\u012bta](\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/07\/11-1-1024x518.jpg\")
<\/figure>\n\n\n\n![\"J\u016bs](\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/07\/12-1-1024x520.jpg\")
<\/figure>\n\n\n\n